NMRA-335140 study for adults with major depression
About this title
Read the official source — NCT06029426Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.
Understand this study
What did researchers investigate?
Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Huntsville and 63 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 383
- Sponsor
- Neumora Therapeutics, Inc.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06029426
- Official title
Show the full official title
A Phase 3, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Huntsville · Phoenix · Bentonville
56 more locations
- Little Rock
- Rogers
- Bellflower
- Garden Grove
- Glendale
- Imperial
- Lafayette
- Long Beach
- Los Angeles
- Oceanside
- Orange
- Riverside
- San Jose
- Sherman Oaks
- Temecula
- Torrance
- Colorado Springs
- Gainesville
- Hallandale
- Jacksonville
- Lauderhill
- Maitland
- Miami
- Miami Lakes
- Orlando
- Tampa
- Marietta
- Chicago
- Evanston
- Warrenville
- Boston
- Methuen
- Watertown
- Bloomfield Hills
- Flowood
- Saint Charles
- Las Vegas
- Brooklyn
- Cedarhurst
- New York
- Staten Island
- Cleveland
- Columbus
- Dayton
- Garfield Heights
- Allentown
- Media
- Plymouth Meeting
- Memphis
- Austin
- Dallas
- Houston
- Wichita Falls
- Charlottesville
- Bellevue
- Everett
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.
Who is behind this study?
The study sponsor is Neumora Therapeutics, Inc.
Did this study involve medication?
Yes. The study involved medication, including NMRA-335140 and Placebo.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
